))
Tail Risks 2021
Manage episode 403072083 series 3234084
Contenu fourni par OCBC Treasury Research and Strategy - Podcast, OCBC Treasury Research, and Strategy - Podcast. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par OCBC Treasury Research and Strategy - Podcast, OCBC Treasury Research, and Strategy - Podcast ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Vaccine haves and have-nots. Stepping into 2021, let’s take a look at the potential tail risks presented by vaccine development. On the positive end, if we can find more “sweet spot” vaccines that are not just effective but relatively easy to roll out in many developing countries, we would see a great upsurge in consumer and business confidence. On the flip side, if such vaccines are not readily available, a sharp dichotomy between the (vaccinated) rich world and (unvaccinated) others could have tremendous negative implications on market sentiment towards emerging markets in 2021.
…
continue reading
136 episodes
Partager
